NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

The standard of care for managing patients with gastrointestinal stromal tumors (GISTs) rapidly changed after the introduction of effective molecularly targeted therapies involving tyrosine kinase inhibitors (TKIs), such as imatinib mesylate and sunitinib malate. A better understanding of the molecu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Demetri, George D., von Mehren, Margaret, Antonescu, Cristina R., DeMatteo, Ronald P., Ganjoo, Kristen N., Maki, Robert G., Pisters, Peter W.T., Raut, Chandrajit P., Riedel, Richard F., Schuetze, Scott, Sundar, Hema M., Trent, Jonathan C., Wayne, Jeffrey D.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103754/
https://ncbi.nlm.nih.gov/pubmed/20457867
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares